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Summary: The most feared early complications after an acute myocardial infarction are ventricular arrhythmias.
These may be initiated by changed concentrations of catecholamines and electrolytes. The present study shows a
reduction of total serum magnesium after acute myocardial infarction which is normalized within a few days.
Further, it could be shown that a more significant decrease of ionized Mg2+ (iMg2+) takes place at the day of acute
myocardial infarction in the total group of myocardial infarction patients (n = 36). A closer investigation reveals
that iMg2"1" was considerably decreased in one third of the patients, whereas two thirds showed minor changes of
iMg2"4" in both directions. The pronounced decrease of iMg2"*" in the first sub-group can be explained by the time
course of free fatty acids in serum. On the day of the myocardial infarction free fatty acids in serum were increased.
This is probably caused by ß-adrenergicrinduced lipolysis due to catecholamines released by the stressful situation
of an acute myocardial infarction. The increased free fatty acids in serum bind Mg24", thus reducing iMg2+. As
long as a beneficial effect of a general Mg infusion in all acute myocardial infarction patients is controversial,
4
" should be measured and Mg infusion therapy should be applied only in patients with low iMg2"1".
Introduction
Lethality after acute myocardial infarction is particu- Several authors described a transient decrease of total
larly caused by ventricular arrhythmias (1—3). Re- serum magnesium during the first 24 hours after acute
cently, several publications indicated that these early myocardial infarction which reached normal values 6
complications are initiated by changed concentrations to 14 days later (19—23). The fall of serum magne-
of catecholamines and electrolytes (4-10), and possi- sium may be explained by increased lipolysis due to
bly by increased formation of free radicals and lipid stress-induced catecholamine release. The free fatty
peroxidatipn (11, 12). In these mechanisms extracellu- acids bind Mg2"1". Thus the free fatty acids in adipo-
lar magnesium may be involved. At reduced serum cytes reduce the concentration of intracellular free
Mg more catecholamines are released (13) and perme- Mg2+ in these cells followed by Mg24" uptake in
ability of Na+ and K+ (14) and lipid peroxidation is adipocytes (24, 25). The increased free fatty acids in
increased (15). Dyckner et al. (16) and Bigg & Chia serum after acute myocardial infarction bind Mg2+
(17) showed that cardiac fibrillations appeared more and consequently the concentration of free Mg2"1" after
frequently in myocardial infarction patients with low acute myocardial infarction may be more reduced than
total serum Mg. Iseri et al. could even improve ther- total serum Mg. Therefore, we investigated the alter-
apy-resistent ventricular arrythmias with Mg2"*" infu- ation of ionized Mg2+ (iMg2"1") in seruni after acute
sions (18). myocardial infarction.
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Materials and Methods
Forty-two patients (37 men and 5 women) with an acute myocar-
dial infarction who were admitted to the Klinikum R. Virchow,
Charlottenburg, Free University Berlin in the time of July 1992
until October 1992 were examined. The average age of the patients
was 62.5 years (range: 40-88 years). The diagnosis "acute myo-
cardial infarction" was determined by ECG, the rise of creatine
kinase and the subjective pain of the patients. At days 1, 2, 3, 5
and 7 after infarction (day 1 = day of infarction) blood was taken
in the morning before breakfast with a plain vacutainer. Blood was
centrifuged within 60 minutes after collection, the temperature not
exceeding 25 °C. iMg2+ in serum was measured with the "Micro-
lyte Magnesium" (Kone Instr. Espoo, Finland) within 60 minutes
after blood centrifugation. The deviation of pH and the resulting
change in iMg2"1" was corrected using the equation:
Ig [iMg2+ (pH)] = Ig [iMg2* (7.4)] + χ (7.4 - pH).
For χ a value of 0.11 was used (26). Total serum magnesium was
determined by atomic absorption spectroscopy. Free fatty acids
were measured with the enzymatic colour test "NEFA c" (27).
Results
Table 1 shows the mean values and standard deviations
of the electrolyte concentrations and free fatty acids
in serum of the patients at day 1 (day of infarction)
and their changes from day 1 to day 2. Because of
missing values at day 2 the number of measurements
varies between 28 and 36. iMg2+ was significantly
lower at day 1 than at day 2, whereas free fatty acids
were significantly higher at day 1 than at day 2. The
Tab. 1 Mean values and standard deviations of electrolytes and
free fatty acids in blood samples of acute myocardial infarction
patients at day 1 and mean differences of these analyte concentra-
tions between day 1 and day 2.
Tab. 2 Rank correlation coefficients (r) between each analysis at
day 1 and day 2 of acute myocardial infarction.
Mgtotai, iMg2+, Catotai, iCa2+, iK+, iNa+, free fatty acid concentra-
tions in serum at day 1 or day 2.
Analysis
iMg2*
Mgtotal
iCa2+
Catotai
iNa+
iK+
Free fatty
acids
Day 1
Mean
mmol/1
0.55
0.79
1.15
2.09
139.37
4.30
2.32
SD
0.07
0.10
0.08
0.34
3.96
0.79
1.81
n
36
36
36
34
36
28
30
Day 2-Day 1
Mean
mmol/1
+0.04
+0.01
+0.02
+0.07
+0.04
+0.07
-0.69
SD
0.07
0.08
0.09
0.31
2.15
0.81
1.16
Sig-
nifi-
cance
**
n.s.
n.s.
n.s.
n.s.
n.s.
**
Levels of significance:
ρ < 0.05
ρ < 0.01
ρ < 0.001
non-significant
number of acute myocardial infarction patients
: ionized free serum magnesium
: total serum magnesium
iCa2+: ionized free serum calcium
Cal0tal· total serum calcium
iNa+: ionized free serum sodium
iK+: ionized free serum potassium
*
**
***
n.s.
n:
iMg2+
Analyses
Day 1
Mgtoial
iMg2+
Catoiai
iCa2+
iK+
iNa+
Free fatty acids
Day 2
Mgtotai
iMg2+
Calotai
iCa2+
iK+
iNa+
Free fatty acids
r
0.54
0.08
0.40
0.24
0.41
0.84
0.55
n
36 *
36 ή. s.
36 *
36 n. s.
28 *
36 ***
31 *
For significance see legend of table 1.
Tab. 3 Rank correlations coefficients (r) between differences of
analyses at day 1 and day 2 of acute myocardial infarction,
e.g.: [AiMg2+ =
Analyses
AiMg24-
AiMg2+
AiMg2*
AMgtotaj
ΔΪΚ+
ΔΜ&013ι
AiK+
AiNa+
AiK+
AiNa+
0.77
0.45
-0.37
0.46
-0.37
36 **
28 *
36 *
28 *
28 *
For significance see legend of table 1.
other electrolytes did not change significantly from
day 1 to day 2. These results show that iMg24" changes
much more from day 1 to 2 after acute myocardial
infarction than Mgtotai.
Table 2 presents the rank correlation coefficients of each
electrolyte species and free fatty acid concentration be-
tween day 1 and day 2. The high correlation coefficient
(r = 0.84) between serum Na+ concentration at day 1
(iNaf) and day 2 (iNaJ) indicates that the sodium con-
centration in serum does not change significantly after
acute myocardial infarction. The concentration of serum
potassium from day 1 to day 2 is less constant (r = 0.41)
and the ionized fractions of Ca2+ (r = 0.24) and Mg2H~
(r = 0.08) are not even significantly correlated between
day 1 and day 2 while Mgtotal (r = 0.54) and Catotal
(r = 0.40) are significantly correlated. These results
show that the individual changes of iMg2+ and iCa2+
from day 1 to day 2 after acute myocardial infarction are
more pronounced than the individual changes of Mgtotal
and Catotai·
In table 3 the rank correlation coefficients of all signifi-
cant correlations between changes of different electro-
lyte species and free fatty acids are listed. The correla-
tion between the changes of iMg2+ and iK4" (r = 0.45)
from day 1 to 2 indicate that potassium and magnesium
are concordantly affected. This is .also shown by a plot
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of the two analytes together with a linear regression (fig.
1). This result may be of clinical importance (see Dis-
cussion). The differences of iNa4" are negatively corre-
lated both with the differences of iMg2* (r = -0.37)
andof iK+(r = -0.37).
It is important to note that there existed no significant
correlation between the changes of iMg24" and the free
fatty acids during the first two days after the acute myo-
cardial infarction. We therefore investigated whether
such a correlation existed in the sub-group with the
strongest relative decrease of iMg24" on the day of the
acute myocardial infarction. For this purpose the distri-
bution of the relative changes of iMg2H" from day 1 to
day 2 is shown in figure 2. As indicated in figure 2 the
patients were divided into three sub-groups with 12 pa-
tients each according to the relative changes of their
iMg2* from day 1 to day 2. Thus, in sub-group A iMg2"1"
was lower at day 1 by -11.5% to -32%. In sub-group
B on the other hand iMg2* was higher by + 1% to
+ 20%. Between these two sub-groups lies a sub-group
with changes of iMg2 + by -11% to 0%.
Time courses of iMg2"1", Mgtotai> iK+ and free fatty acids
were plotted for sub-groups A and B (see figs 3—6). In
the patients of sub-group A at the day of infarction
iMg2+ (fig. 3 a), Mgtotal (fig. 4 a) and iK+ (fig. 5 a) were
low, increased to day 2 and remained almost constant
thereafter. In these patients free fatty acids (fig. 6 a) were
highest at day 1 and decreased thereafter.
In patients of sub-group B, who were selected by their
high iMg2"*" at day 1, Mgtotai a^d iK+ were also highest
at day 1 and decreased later. Free fatty acids remained
almost constant throughout day 1 to day 7 (fig. 3 b, 4b,
0.2-
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φ
- 3 2^ - 1 0 1 2 3
IK+(day2) - IK+(day 1) [mmol/l]
Fig. l Scatter plot of the differences of iMg2+ versus the differ-
ences of iK"1" from day 1 to day 2 of acute myocardial infarction.
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Fig. 2 Distribution of fractions of iMg2+ on day 2 after myocar-
dial infarction: (iMgi* - iMg2*) / iMgi*. n: numbers of patients
with given fractions of iMg2+ at day 2. A: sub-group of 12 patients
with lowest iMg2"1", B: sub-group of 12 patients with highest iMg2*
at day of infarction.
5b, 6b). Time courses of iCa2*, Catotai and iNa+ are
not shown, since their changes with time as well as their
differences between sub-groups were not significant.
Discussion
Low iMg2+ was observed at the day of infarction in the
total group of myocardial infarction patients. A more
thorough analysis showed that acute myocardial infarc-
tion patients did not behave homogeneously with respect
to iMg2+, Mgtotab iK+ and free fatty acids. Therefore,
the acute myocardial infarction patients were divided
into 3 sub-groups according to their relative changes of
iMg24" from day 1 to day 2.
Sub-group A consisted of patients with the strongest in-
creases of iMg2"1" from day 1 to day 2. In this sub-group
Mgtotai snd iMg2"1" in serum were low immediately after
acute myocardial infarction (day 1) and iMg2"1" reached
normal values at day 2. The changes of iK+ are closely
correlated to the changes of iMg2+. A close relationship
was also shown for total Mg and iK+ in serum (19).
The behaviour of total serum Mg is in accordance with
earlier results (19-23), which showed that the low total
serum Mg after acute myocardial infarction normalized
during the following few days. In the present study we
additionally measured iMg2+ and found that in the pa-
tients of sub-group A, iMg2+ at the day of acute myocar-
dial infarction was much more reduced than total Mg.
This result can be explained by the time course of free
fatty acids in serum. At day 1 of acute myocardial in-
farction, free fatty acids were increased. This is probably
caused by -adrenergic-induced lipolysis due to cate-
cholamines released by the stressful situation of acute
Eur J Clin Chem Clin Biochem 1995; 33 (No 9)
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Fig. 3 Time courses of iMg2"1" concentration in serum of acute myocardial infarction patients:
sub-group A (a) and sub-group Β (b). Mean values ± SD.
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Fig. 4 Time courses of Mgtotai concentration in serum of acute myocardial infarction patients:
sub-group A (a) and sub-group Β (b). Mean values ± SD.
myocardial infarction (4, 28). The increased free fatty
acids in serum bind Mg2+ and Ca2+, thus reducing
iMg2+. iCa2+ may not be reduced since it can be rapidly
regulated by parathormone.
The transient reduction of total serum Mg can be ex-
plained by a transient uptake of extracellular Mg2+ by
adipocytes (24, 25). Catecholamines increase lipolysis
in adipocytes. The released free fatty acids in adipocytes
bind intracellular Mg2+ and thus reduce intracellular
free Mg2+ in the adipocytes. This is followed by uptake
of extracellular Mg2+ by adipocytes (25), resulting in a
reduction of total serum Mg.
Our findings may have clinical consequences. We sug-
gest that only acute myocardial infarction patients with
decreased iMg2+ and iK+ should be infused with Mg2+.
In the case of reduced iK+, K+ infusion is common
clinical practice. However, in two major clinical studies
LIMIT 2 (29-31) and ISIS 4 (32, 35) and in 12 small
trials controversial effects of Mg2+ infusions in acute
myocardial infarct patients were found and in a few
meta-analyses the controversial results were discussed.
For a review of the literature see 1. c. (36).
While LIMIT 2 (29-31) found positive effects, this was
not confirmed in ISIS 4 (32, 35). The missing beneficial
effect of ISIS 4 was explained and experimentally
proven by the late time point of Mg2+ infusion, e. g.
after lysis (33). It was also suggested that the high Mg2"1"
dose used in ISIS 4 may have produced negative side
effects (34).
As long as it remains controversial whether a general
Mg2+ infusion of all acute myocardial infarction pa-
tients is beneficial, we suggest that iMg2+ should be
measured and Mg2+ should be infused only in acute
myocardial infarction patients with low iMg2"1". Since in
most hospitals the equipment for iMg2"1" estimation is
not available, hypokalaemia may be taken as indication
for low iMg2"1". This compromise can be justified by the
significant correlation between the changes of iK+ and
Eur J Clin Chem Clin Biochem 1995; 33 (No 9)
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Fig. 5 Time courses of iK* concentration in serum of acute myocardial infarction patients:
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Fig. 6 Time courses of free fatty acid concentration in serum of acute myocardial infarction patients:
sub-group A (a) and sub-group B (b). Mean values ± SD.
after acute myocardial infarction. However, as
figure 1 shows, this compromise is by far not optimal.
Therefore, iMg2+ measurements should be installed as
clinical routine for acute myocardial infarction pa-
tients.
Since reduction of iMg2+ can increase the release of
catecholamines (13) and in cooperation with catechola-
mines may intensify cardiac arrhythmia (4), Mg2+ in-
fusion should be an additional beneficial treatment of
acute myocardial infarction patients with low iMg2+.
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